Dexmedetomidine and Renal Transplants



Status:Active, not recruiting
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:7/1/2018
Start Date:October 2013
End Date:September 2019

Use our guide to learn which trials are right for you!

Investigators aim to retrospectively research patients undergoing renal transplants that
received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal
function. Investigators hope to elucidate any association between renal transplant patients
and perioperative dexmedetomidine administration, these include (but are not limited to) UOP,
Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will
research both living and cadaveric renal transplants.


Inclusion Criteria: Patients greater than or equal to 18 years old that underwent renal
transplant at UC Davis Medical Center -

Exclusion Criteria: Patients that did not undergo renal transplants and patients less than
18 years old will be excluded from the study.
We found this trial at
1
site
Sacramento, California 95817
?
mi
from
Sacramento, CA
Click here to add this to my saved trials